Dijkstrand
Board
2 directors, last change in 2024Director (not named in the articles)
since 13-12-2023
term until 25-06-2028
earlier director, until 17-01-2024
listed in the 2025 annual accounts, filed on 09-07-2026
Director (not named in the articles)
since 13-12-2023
term until 25-06-2028
earlier director, until 17-01-2024
listed in the 2025 annual accounts, filed on 09-07-2026
- Signing authorityThe articles say who may bind the company, for example by signing a contract.
- A managing director alonedeed of 17-01-2024
Mandates through the years
2 names, the dashed line is todayGerda De Wilde
Director (not named in the articles)
Director (not named in the articles)
Ivan Valcke
Director (not named in the articles)
Director (not named in the articles)
BoardEarlierRest of the termmandate already running before its first mention
Mandates as a list
- Gerda De Wilde
- Director (not named in the articles), from 18-01-2011 to date
- Director, until 17-01-2024
- Ivan Valcke
- Director (not named in the articles), from 18-01-2011 to date
- Director, until 17-01-2024
Control
Parent
Equity €2.1m
Profit €249,781 in 2025 (profit €257,829 in 2024)
Checked score 96
100%
This company
Dijkstrand
Equity -€70,125
Loss €15,954 in 2025
Capital
- Capital
- €347,050.93
- Source
- 2025 annual accounts
Owners through the years
as the annual accounts name themOwners as a list
- DR. GERDA DE WILDE OFTALMOLOOG
Source: lists of holdings in the owners' accounts
Articles of association
deed of 17-01-2024 (in Dutch)- Board ruleThese rules set how the board is made up, meets and takes decisions.
- Term of at most 6 years
- Profit allocationThe articles set how profit is distributed. A BV may only pay out after a balance-sheet and liquidity test.
- “Gewone meerderheid van stemmen, raad van bestuur”
- Annual meetingThe shareholders approve the annual accounts, among other things, at the annual meeting.
- “5. Jaarvergadering, voorwaarden van toelating en van stemuitoefening: De gewone algemene vergadering wordt jaarlijks gehouden op de…”